Follow the Cantargia AB share price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Cantargia AB has published 3 insider filings. Market capitalisation: €522.1m. The latest transaction was filed on 2 April 2026 (Purchase). Among the most active insiders: David Liberg. The full history is openly available.
Analysts rate Cantargia AB Strong Buy (bullish), based on 2 analysts. Average price target: SEK 10.00.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3 of 3 declarations